| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers A > Headlines for Arch Therapeutics Inc. > News item |
Arch Therapeutics amends series C warrants sold to Cranshire Capital
Warrants will now expire on July 2, 2015, extended from June 2, 2015
By Devika Patel
Knoxville, Tenn., June 1 – Arch Therapeutics, Inc. amended the terms of the series C warrants held by Cranshire Capital Master Fund, Ltd. on May 30, according to an 8-K filed Monday with the Securities and Exchange Commission.
The warrants will now expire on July 2, 2015, extended from June 2, 2015.
The life science company is based in Wellesley, Mass.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.